Phase 1 study of DS-3201b to assess the effects of itraconazole and fluconazole on the pharmacokinetics of single oral administration of DS-3201b tablets in healthy Japanese subjects
Latest Information Update: 22 Apr 2022
At a glance
- Drugs Valemetostat (Primary) ; Fluconazole; Itraconazole
- Indications Acute myeloid leukaemia; Adult T-cell leukaemia-lymphoma; B-cell lymphoma; Diffuse large B cell lymphoma; Non-Hodgkin's lymphoma; Peripheral T-cell lymphoma; Precursor cell lymphoblastic leukaemia-lymphoma; Prostate cancer; Renal cell carcinoma; Small cell lung cancer; Urogenital cancer
- Focus Pharmacokinetics
- Sponsors Daiichi Sankyo Company
- 18 Mar 2022 Results presented at the 123rd Annual Meeting of the American Society for Clinical Pharmacology and Therapeutics
- 26 Sep 2018 Status changed from active, no longer recruiting to completed.
- 27 Apr 2018 Status changed from not yet recruiting to active, no longer recruiting.